Developer docs
API playgroundTry for free, no card

Search company profiles

Qx Medical

Full company profile

uuid000ee6a

Namestring
Qx Medical
Legal namestring
QXMédical, LLC
Websiteurl
qxmedical.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

QXMédical is a privately held medical device company that designs and manufactures first-in-class devices for minimally invasive coronary, peripheral, and endovascular interventions. Founded in 2007 in Montreal, Canada, the company relocated primary operations to Saint Paul, Minnesota in 2010 and operates from a corporate headquarters and integrated Technology & Manufacturing Center at 2820 Patton Road. Its product portfolio is anchored by two proprietary technology platforms: a balloon technology platform driving applications including vessel occlusion, stent graft expansion, sizing, embolectomy, and PTA/PTCA; and a catheter technology platform powering delivery, procedural support, and crossing catheters. Commercialized products include the Q50 PLUS and Q50X stent graft balloon catheters for AAA/TAA, the EVAR Balloon Catheter (over 100,000 clinical cases), the Occlusion Balloon Catheter for trauma and hemorrhage control, and the Boosting Catheter guide extension catheter (over 50,000 clinical uses worldwide). The pipeline also includes i-FLEX bioresorbable embolization particles, developed and commercialized through subsidiary BiologiQ.

The company monetizes primarily through hardware sales of prescription medical devices to healthcare providers and through licensing/royalty arrangements tied to its BiologiQ subsidiary (worldwide exclusive rights to bioresorbable embolic technology licensed from the University of Minnesota in 2019). Distribution is hybrid: a Strategic Partner Program with companies of all sizes including some of the largest U.S. medical device companies, supplemented by direct sales and regional distributors. End customers are interventional cardiologists, interventional radiologists, vascular surgeons, and emergency/trauma care providers in North America and Europe. The company is ISO 13485:2016 certified, holds multiple FDA 510(k) clearances, and achieved EU MDR certification for the Boosting Catheter in July 2024. A definitive settlement with Teleflex in October 2025 cleared patent litigation, enabling U.S. market launch of the Boosting Catheter in 2026.

Short descriptiontext

QXMédical is a privately held medical device company that designs and manufactures proprietary balloon and delivery catheter devices for minimally invasive coronary, peripheral, and endovascular interventions, serving interventional cardiologists, vascular surgeons, interventional radiologists, and emergency/trauma care providers through channel partners and direct sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSaint Paul, United States
HQ citystring
Saint Paul
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
balloon catheters, guide extension catheters, embolization particles, vascular intervention devices, minimally invasive medical devices
Industry2 codes
PRIMARYHLAHAFAE
Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAKABAB
Interventional Cardiology (PCI/Structural Heart)
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Vascular Intervention Devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of proprietary balloon catheters, guide extension catheters, and embolic agents to healthcare providers and medical facilities

qxmedical.com
2Licensed Technology Commercialization
TypeLicensing Royalties
Description

Commercialization of bioresorbable embolic technology licensed from University of Minnesota through subsidiary BiologiQ

qxmedical.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1BiologiQ
Description

Subsidiary of QXMédical managing bioresorbable embolic technology development, regulatory submissions and commercialization.

qxmedical.com
Core offering1 text field

Qx Medical designs and manufactures first-in-class medical devices for minimally invasive coronary, peripheral, and endovascular interventions. The product portfolio centers on proprietary balloon catheters and delivery catheters for vessel occlusion, stent graft expansion, and procedural support, alongside bioresorbable embolization particles developed through subsidiary BiologiQ.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 100,000 clinical cases using EVAR Balloon Catheter technology
+2 more records
Product overview1 text field

QXMédical is a medical device company that designs and manufactures first-in-class devices for minimally invasive coronary, peripheral, and endovascular interventions. The company's core technology platforms center on proprietary balloon technology (driving applications including vessel occlusion, stent graft expansion, sizing, embolectomy, PTA/PTCA) and catheter technology (for delivery catheters, procedural support devices, crossing catheters). The product portfolio includes: stent graft balloon catheters (Q50 PLUS, Q50X), guide extension catheters (Boosting Catheter), embolization particles (i-FLEX), EVAR Balloon Catheters, and Occlusion Balloon Catheters. Products serve endovascular interventions, coronary and peripheral vascular interventions, and emergency/trauma care applications.

Product and service1 record
1Q50 PLUS Stent Graft Balloon Catheter
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-06-10
Description

QXMédical acquired worldwide exclusive rights to bioresorbable embolic technology developed by researchers and physicians at the University of Minnesota. This novel technology provides resorbable and drug-loadable microspheres and hydrogels for embolization procedures. The technology is managed through BiologiQ, a subsidiary of QXMédical, for final development, regulatory submissions and commercialization.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Teleflex is a large U.S. medical device company that markets guide extension catheters and other interventional cardiology products. QXMédical's Boosting Catheter is a direct competitor to Teleflex's offering, as evidenced by the October 2025 patent settlement between the two companies.

TypeBroad incumbent
Description

Boston Scientific is a large incumbent in interventional cardiology and peripheral vascular intervention with broad catheter, guide extension, and embolic therapy portfolios (including the legacy BTG embolic franchise). QXMédical's coronary and peripheral catheter products compete in overlapping procedure categories with Boston Scientific's installed base.

TypeBroad incumbent
Description

Medtronic is a global medical device leader with deep portfolios in interventional cardiology, peripheral vascular and endovascular therapies. QXMédical's catheter and balloon platforms for PCI, EVAR and embolization compete for the same physician customers and hospital budgets as Medtronic's broad cardiovascular franchise.

TypeBroad incumbent
Description

Abbott Vascular is a leading manufacturer of coronary and peripheral vascular intervention devices, including guide catheters, guide extension systems, and balloon technologies. QXMédical's guide extension and EVAR balloon catheter products address overlapping use cases in Abbott's core catheter lab markets.

TypeDirect peer
Description

Terumo is a global medical device company with a strong portfolio in interventional cardiology and peripheral vascular catheters, including guide extension and balloon products. QXMédical's Boosting Catheter and balloon catheter portfolio directly competes in the same cath lab and IR procedural categories as Terumo.

TypeDirect peer
Description

Penumbra is a focused vascular intervention company with catheter-based technologies for thrombectomy, embolization and peripheral vascular procedures. QXMédical's embolization particle and occlusion balloon catheter products compete in overlapping endovascular and trauma embolization markets served by Penumbra.

TypeDirect peer
Description

Inari Medical develops catheter-based therapies for venous thromboembolism and peripheral vascular disease, with significant overlap in catheter engineering and endovascular treatment of complex vascular disease. QXMédical's balloon and delivery catheter platforms address similar interventional procedure use cases.

TypeDirect peer
Description

Merit Medical is a manufacturer of disposable interventional devices including catheters, balloon inflation devices, and embolization products. QXMédical's balloon catheters and embolization particles are direct comparables to Merit's peripheral intervention and embolic therapy portfolio.

TypeDirect peer
Description

AngioDynamics is a medical device company focused on vascular access, peripheral vascular disease, and oncology/embolization therapies. QXMédical's EVAR balloon catheters, occlusion balloons, and i-FLEX embolization particles compete in similar peripheral vascular and embolization procedure categories.

TypeEmerging player
Description

Surmodics is a smaller medical device company with a peripheral vascular intervention portfolio including drug-coated balloons and specialty catheter technologies. QXMédical's peripheral balloon and catheter products are comparable in scale and target use cases, making Surmodics a useful emerging peer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Qx Medical

Vascular Intervention Devicesqxmedical.com

QXMédical is a privately held medical device company that designs and manufactures proprietary balloon and delivery catheter devices for minimally invasive coronary, peripheral, and endovascular interventions, serving interventional cardiologists, vascular surgeons, interventional radiologists, and emergency/trauma care providers through channel partners and direct sales.

What Qx Medical does

QXMédical is a privately held medical device company that designs and manufactures first-in-class devices for minimally invasive coronary, peripheral, and endovascular interventions. Founded in 2007 in Montreal, Canada, the company relocated primary operations to Saint Paul, Minnesota in 2010 and operates from a corporate headquarters and integrated Technology & Manufacturing Center at 2820 Patton Road. Its product portfolio is anchored by two proprietary technology platforms: a balloon technology platform driving applications including vessel occlusion, stent graft expansion, sizing, embolectomy, and PTA/PTCA; and a catheter technology platform powering delivery, procedural support, and crossing catheters. Commercialized products include the Q50 PLUS and Q50X stent graft balloon catheters for AAA/TAA, the EVAR Balloon Catheter (over 100,000 clinical cases), the Occlusion Balloon Catheter for trauma and hemorrhage control, and the Boosting Catheter guide extension catheter (over 50,000 clinical uses worldwide). The pipeline also includes i-FLEX bioresorbable embolization particles, developed and commercialized through subsidiary BiologiQ.

The company monetizes primarily through hardware sales of prescription medical devices to healthcare providers and through licensing/royalty arrangements tied to its BiologiQ subsidiary (worldwide exclusive rights to bioresorbable embolic technology licensed from the University of Minnesota in 2019). Distribution is hybrid: a Strategic Partner Program with companies of all sizes including some of the largest U.S. medical device companies, supplemented by direct sales and regional distributors. End customers are interventional cardiologists, interventional radiologists, vascular surgeons, and emergency/trauma care providers in North America and Europe. The company is ISO 13485:2016 certified, holds multiple FDA 510(k) clearances, and achieved EU MDR certification for the Boosting Catheter in July 2024. A definitive settlement with Teleflex in October 2025 cleared patent litigation, enabling U.S. market launch of the Boosting Catheter in 2026.

Qx Medical firmographics

Firmographics
Name
Qx Medical
Legal name
QXMédical, LLC
Website
https://qxmedical.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
QXMédical is a privately held medical device company that designs and manufactures proprietary balloon and delivery catheter devices for minimally invasive coronary, peripheral, and endovascular interventions, serving interventional cardiologists, vascular surgeons, interventional radiologists, and emergency/trauma care providers through channel partners and direct sales.
Ownership category
akta.pro rank

Qx Medical industry classification

Industry
Product category
Vascular Intervention Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAE
Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAKABAB
Interventional Cardiology (PCI/Structural Heart)

Keywords

  • Balloon catheters
  • Guide extension catheters
  • Embolization particles
  • Vascular intervention devices
  • Minimally invasive medical devices

Where Qx Medical is headquartered

Location

Headquarters

HQ city
Saint Paul
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Qx Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: Sale of proprietary balloon catheters, guide extension catheters, and embolic agents to healthcare providers and medical facilities
  2. Licensed Technology Commercialization: Commercialization of bioresorbable embolic technology licensed from University of Minnesota through subsidiary BiologiQ

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Qx Medical product offering

Product offering

Core offering

Qx Medical designs and manufactures first-in-class medical devices for minimally invasive coronary, peripheral, and endovascular interventions. The product portfolio centers on proprietary balloon catheters and delivery catheters for vessel occlusion, stent graft expansion, and procedural support, alongside bioresorbable embolization particles developed through subsidiary BiologiQ.

Product overview

QXMédical is a medical device company that designs and manufactures first-in-class devices for minimally invasive coronary, peripheral, and endovascular interventions. The company's core technology platforms center on proprietary balloon technology (driving applications including vessel occlusion, stent graft expansion, sizing, embolectomy, PTA/PTCA) and catheter technology (for delivery catheters, procedural support devices, crossing catheters). The product portfolio includes: stent graft balloon catheters (Q50 PLUS, Q50X), guide extension catheters (Boosting Catheter), embolization particles (i-FLEX), EVAR Balloon Catheters, and Occlusion Balloon Catheters. Products serve endovascular interventions, coronary and peripheral vascular interventions, and emergency/trauma care applications.

Differentiator

Problem solved

Functional benefit

Brands

  • BiologiQ: Subsidiary of QXMédical managing bioresorbable embolic technology development, regulatory submissions and commercialization.

Products and services

  • Q50 PLUS Stent Graft Balloon Catheter

Quantifiable outcome

  • Over 100,000 clinical cases using EVAR Balloon Catheter technology
  • +2 more outcomes

Companies that use Qx Medical

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Qx Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Qx Medical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • University of MinnesotacoreStrategic or Co-development Partner · 10 June 2019QXMédical acquired worldwide exclusive rights to bioresorbable embolic technology developed by researchers and physicians at the University of Minnesota. This novel technology provides resorbable and drug-loadable microspheres and hydrogels for embolization procedures. The technology is managed through BiologiQ, a subsidiary of QXMédical, for final development, regulatory submissions and commercialization.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Qx Medical competitors and assessment

Company assessment

Direct peers

  • Teleflex: Teleflex is a large U.S. medical device company that markets guide extension catheters and other interventional cardiology products. QXMédical's Boosting Catheter is a direct competitor to Teleflex's offering, as evidenced by the October 2025 patent settlement between the two companies.
  • Terumo: Terumo is a global medical device company with a strong portfolio in interventional cardiology and peripheral vascular catheters, including guide extension and balloon products. QXMédical's Boosting Catheter and balloon catheter portfolio directly competes in the same cath lab and IR procedural categories as Terumo.
  • Penumbra: Penumbra is a focused vascular intervention company with catheter-based technologies for thrombectomy, embolization and peripheral vascular procedures. QXMédical's embolization particle and occlusion balloon catheter products compete in overlapping endovascular and trauma embolization markets served by Penumbra.
  • Inari Medical: Inari Medical develops catheter-based therapies for venous thromboembolism and peripheral vascular disease, with significant overlap in catheter engineering and endovascular treatment of complex vascular disease. QXMédical's balloon and delivery catheter platforms address similar interventional procedure use cases.
  • Merit Medical Systems: Merit Medical is a manufacturer of disposable interventional devices including catheters, balloon inflation devices, and embolization products. QXMédical's balloon catheters and embolization particles are direct comparables to Merit's peripheral intervention and embolic therapy portfolio.
  • AngioDynamics: AngioDynamics is a medical device company focused on vascular access, peripheral vascular disease, and oncology/embolization therapies. QXMédical's EVAR balloon catheters, occlusion balloons, and i-FLEX embolization particles compete in similar peripheral vascular and embolization procedure categories.

Broad incumbents

  • Boston Scientific: Boston Scientific is a large incumbent in interventional cardiology and peripheral vascular intervention with broad catheter, guide extension, and embolic therapy portfolios (including the legacy BTG embolic franchise). QXMédical's coronary and peripheral catheter products compete in overlapping procedure categories with Boston Scientific's installed base.
  • Medtronic: Medtronic is a global medical device leader with deep portfolios in interventional cardiology, peripheral vascular and endovascular therapies. QXMédical's catheter and balloon platforms for PCI, EVAR and embolization compete for the same physician customers and hospital budgets as Medtronic's broad cardiovascular franchise.
  • Abbott Vascular: Abbott Vascular is a leading manufacturer of coronary and peripheral vascular intervention devices, including guide catheters, guide extension systems, and balloon technologies. QXMédical's guide extension and EVAR balloon catheter products address overlapping use cases in Abbott's core catheter lab markets.

Emerging players

  • Surmodics: Surmodics is a smaller medical device company with a peripheral vascular intervention portfolio including drug-coated balloons and specialty catheter technologies. QXMédical's peripheral balloon and catheter products are comparable in scale and target use cases, making Surmodics a useful emerging peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Qx Medical social profiles

Digital presence

Qx Medical compliance and trust

Trust signal

Compliance1 record

Qx Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Qx Medical leadership team

Management profile

Number of profiles

Profiles3 records

Qx Medical subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Qx Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Qx Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qx Medical

What does Qx Medical do?

Qx Medical designs and manufactures first-in-class medical devices for minimally invasive coronary, peripheral, and endovascular interventions. The product portfolio centers on proprietary balloon catheters and delivery catheters for vessel occlusion, stent graft expansion, and procedural support, alongside bioresorbable embolization particles developed through subsidiary BiologiQ.

Is Qx Medical a public or private company?

Qx Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Qx Medical founded?

Qx Medical was founded in 2007. It employs 11 to 50 people.

Where is Qx Medical based?

Qx Medical is headquartered in Saint Paul, United States, in the North America region.

How does Qx Medical make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are licensed Technology Commercialization.

Who are Qx Medical's main competitors?

Direct peers on record are Teleflex, Terumo, Penumbra, Inari Medical, Merit Medical Systems and AngioDynamics. Broad incumbents are Boston Scientific, Medtronic and Abbott Vascular. Surmodics is listed as an emerging player.

Does Qx Medical have an API?

No public API is recorded for Qx Medical.

What industry is Qx Medical in?

Qx Medical's product category is Vascular Intervention Devices. Its primary akta.pro industry code is HLAHAFAE, Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy), with a secondary code of HLAKABAB, Interventional Cardiology (PCI/Structural Heart). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales